Table 4

Number and percentage of patients achieving LDL particle and LDL cholesterol goals

Baseline6 weeks12 weeks
LDL-P <1,000 nmol/l
    Rosuvastatin030/122 (25)45/166 (27)
    Atorvastatin012/101 (12)17/91 (19)
    Placebo01/55 (2)
LDL-P <1,300 nmol/l
    Rosuvastatin4/122 (3)70/122 (57)115/166 (69)
    Atorvastatin3/101 (3)60/101 (59)50/91 (55)
    Placebo3/55 (5)1/55 (2)
LDL cholesterol <2.59 mmol/l
    Rosuvastatin099/162 (61)185/232 (80)
    Atorvastatin070/151 (46)85/145 (59)
    Placebo01/78 (1)
  • Data aren(%). LDL particle concentration (LDL-P) <1,000 nmol/l corresponds to the 20th percentile and <1,300 nmol/l to the 50th percentile of values from the MESA study (10).